Efficacy of dupilumab as an alternative to corticosteroids in the treatment of exacerbations of allergic bronchopulmonary aspergillosis

被引:1
|
作者
Hamakawa, Masamitsu [1 ,2 ]
Ishida, Tadashi [1 ]
机构
[1] Kurashiki Cent Hosp, Dept Resp Med, Okayama, Japan
[2] Kurashiki Cent Hosp, Dept Resp Med, 1-1-1 Miwa, Kurashiki, Okayama 7108602, Japan
来源
RESPIROLOGY CASE REPORTS | 2024年 / 12卷 / 04期
关键词
ABPA; allergic bronchopulmonary aspergillosis; asthma; dupilumab;
D O I
10.1002/rcr2.1354
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The pathogenesis of allergic bronchopulmonary aspergillosis involves not only eosinophils but also plasma cells that produce immunoglobulin E. Dupilumab may be an effective alternative to corticosteroids because it inhibits T cell to plasma cell differentiation by blocking IL4. The pathogenesis of ABPA involves not only eosinophils but also plasma cells that produce IgE, which is responsible for type I allergic mechanisms. Dupilumab may be an effective alternative to corticosteroids because it inhibits T cell to plasma cell differentiation by blocking IL4. image
引用
收藏
页数:2
相关论文
共 50 条
  • [1] TREATMENT OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS WITH INHALED CORTICOSTEROIDS
    BALTER, MS
    REBUCK, AS
    RESPIRATORY MEDICINE, 1992, 86 (05) : 441 - 442
  • [2] Dupilumab treatment for allergic bronchopulmonary aspergillosis: A case series
    Ramonell, Richard Paul
    Lee, F. Eun-Hyung
    Swenson, Colin
    Kuruvilla, Merin
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (02): : 742 - 743
  • [3] Diagnosis of Allergic Bronchopulmonary Aspergillosis Exacerbations
    Giavina-Bianchi, Pedro
    Kalil, Jorge
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (06): : 1599 - 1600
  • [4] Efficacy of omalizumab treatment in allergic bronchopulmonary aspergillosis
    Martorell, C.
    Morales, C.
    Raducan, I
    Cadavid, S.
    Sastre, A.
    Pelaez, A.
    ALLERGY, 2013, 68 : 362 - 363
  • [5] Successful treatment with dupilumab in mepolizumab-resistant allergic bronchopulmonary aspergillosis
    Kawasaki, Yasutaka
    Nishiki, Kazuaki
    Ishizaki, Takeshi
    RESPIRATORY MEDICINE CASE REPORTS, 2024, 47
  • [6] DUPILUMAB IN THE TREATMENT OF REFRACTORY ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS WITH SUPERIMPOSED REFRACTORY ASTHMA
    Yingchoncharoen, Pitchaporn
    Evans, Abbie
    Chaisrimaneepan, Nattanicha
    Mathew, Joscilin
    Wyatt, Divya Vangipuram
    Motes, Arunee
    Singh, Tushi
    Peralta, Cesar
    Nugent, Kenneth M.
    CHEST, 2024, 166 (04) : 59A - 60A
  • [7] Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations
    Sehgal, Inderpaul Singh
    Agarwal, Ritesh
    EUROPEAN RESPIRATORY REVIEW, 2014, 23 (131): : 149 - 152
  • [8] MOLD COUNTS AND EXACERBATIONS OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
    RADIN, RC
    GREENBERGER, PA
    PATTERSON, R
    GHORY, A
    CLINICAL ALLERGY, 1983, 13 (03): : 271 - 275
  • [9] Allergic bronchopulmonary aspergillosis in identical twins: Effectiveness of dupilumab
    Lamothe, Pedro A.
    Runnstrom, Martin
    Smirnova, Natalia
    Flores, Flavio C.
    Shepherd, Aaron
    Park, Jiwon
    Lee, F. Eun-Hyung
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (05): : 1556 - 1558.e2
  • [10] A case of allergic bronchopulmonary aspergillosis in a child: Response to dupilumab
    Meneses, Jaime V.
    Clar, Miriam
    Bracamonte, Stephanie C.
    Gomez, Elisa
    Martin, Aranzazu
    Borja, Jesus
    Galindo, Pedro A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (08): : 2178 - 2179